* Aspen Aerogels Inc ASPN.N reported a quarterly adjusted
loss
of 19 cents per share for the quarter ended in September,
higher than the same quarter last year, when the company
reported EPS of -75 cents. The mean expectation of
nine analysts for the quarter was for a loss of 27 cents per
share. Wall Street expected results to range from -33 cents
to -21 cents per share.
* Revenue rose 65.5% to $60.76 million from a year ago;
analysts
expected $51.84 million.
* Aspen Aerogels Inc's reported EPS for the quarter was a
loss
of 19 cents.
* The company reported a quarterly loss of $13.07 million.
* Aspen Aerogels Inc shares had fallen by 10.2% this
quarter and
lost 34.5% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had risen by
about 23% in
the last three months.
* In the last 30 days, there have been no negative revisions
of
earnings estimates
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 9 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the specialty
chemicals
peer group is also "buy"
Wall Street's median 12-month price target for Aspen Aerogels
Inc is $23.00
This summary was machine generated from LSEG data November 1 at
11:13 p.m. UTC. All figures in US dollars unless otherwise
stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Sep. 30 2023 -0.27 -0.19 Beat
Jun. 30 2023 -0.36 -0.22 Beat
Mar. 31 2023 -0.40 -0.24 Beat
Dec. 31 2022 -0.30 -0.20 Beat